logo
Plus   Neg
Share
Email

Sienna Biopharma To File For Bankruptcy

Sienna Biopharmaceuticals Inc. (SNNA) said Tuesday that it has elected to file a voluntary petition to allow restructuring under Chapter 11 of the Bankruptcy Code.

"The protections afforded by Chapter 11 provide for an orderly restructuring process as well as additional time to pursue financial and strategic alternatives," said Frederick C. Beddingfield III, M.D., Ph.D., President and Chief Executive Officer of Sienna.

In Tuesday Pre-market trade, SNNA is trading at $0.3788, down $0.29 or 43.74 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The University of Phoenix has agreed to pay a record $191 million to settle Federal Trade Commission charges alleging that the university used deceptive advertisements. According to the FTC, the university used deceptive advertisements that falsely touted their relationships and job opportunities... General Motors introduced new versions of its Chevrolet Tahoe and Suburban full-size SUVs that are bigger than previous models, offer more interior space and feature more advanced technology. The new vehicles join the new Silverado and Silverado HD as part of a complete redesign of Chevrolet's full-size truck and SUV lineup within 24 months. They will go on sale in mid-2020 in North America. Apple unveiled a new feature for the Apple Card, enabling cardholders to buy a new iPhone in 24 monthly installments without paying interest. In October, during Apple's earnings call, CEO Tim Cook had announced the tech giant's plans to introduce this feature. The Apple Card, Apple's first credit card, was introduced by the tech giant in March in partnership with Goldman Sachs and Mastercard.
RELATED NEWS
Follow RTT
>